Literature DB >> 19674985

Rheumatoid arthritis after Chikungunya fever: a prospective follow-up study of 21 cases.

E Bouquillard, B Combe.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19674985     DOI： 10.1136/ard.2008.097626

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  18 in total

1.  Therapy with CTLA4-Ig and an antiviral monoclonal antibody controls chikungunya virus arthritis.

Authors:  Jonathan J Miner; Lindsey E Cook; Jun P Hong; Amber M Smith; Justin M Richner; Raeann M Shimak; Alissa R Young; Kristen Monte; Subhajit Poddar; James E Crowe; Deborah J Lenschow; Michael S Diamond
Journal:  Sci Transl Med       Date:  2017-02-01       Impact factor: 17.956

Review 2.  Environmental factors and hormones in the development of rheumatoid arthritis.

Authors:  Deshiré Alpízar-Rodríguez; Axel Finckh
Journal:  Semin Immunopathol       Date:  2017-04-27       Impact factor: 9.623

Review 3.  Chikungunya in the region of the Americas. A challenge for rheumatologists and health care systems.

Authors:  Carlos Pineda; Roberto Muñoz-Louis; Carlo V Caballero-Uribe; Diego Viasus
Journal:  Clin Rheumatol       Date:  2016-08-24       Impact factor: 2.980

4.  Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infection.

Authors:  Weiqiang Chen; Suan-Sin Foo; Adam Taylor; Aleksei Lulla; Andres Merits; Linda Hueston; Mark R Forwood; Nicole C Walsh; Natalie A Sims; Lara J Herrero; Suresh Mahalingam
Journal:  J Virol       Date:  2014-10-22       Impact factor: 5.103

5.  Serological Responses in Patients Infected with Mayaro Virus and Evaluation of Cross-Protective Responses against Chikungunya Virus.

Authors:  Nathen E Bopp; Kara J Jencks; Crystyan Siles; Carolina Guevara; Stalin Vilcarromero; Diana Fernández; Eric S Halsey; Julia S Ampuero; Patricia V Aguilar
Journal:  Am J Trop Med Hyg       Date:  2021-11-29       Impact factor: 2.345

6.  Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis: a 24-week randomized controlled open label study.

Authors:  Vinod Ravindran; George Alias
Journal:  Clin Rheumatol       Date:  2016-10-04       Impact factor: 2.980

7.  Epidemiology, clinical manifestations, and diagnosis of Chikungunya fever: lessons learned from the re-emerging epidemic.

Authors:  Alladi Mohan; D H N Kiran; I Chiranjeevi Manohar; D Prabath Kumar
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

8.  Risk factor assessment of rheumatoid arthritis in North Kerala.

Authors:  Binoy Paul; Rosh Pariyapurath
Journal:  Eur J Rheumatol       Date:  2018-08-07

9.  Perceived morbidity and community burden after a Chikungunya outbreak: the TELECHIK survey, a population-based cohort study.

Authors:  Patrick Gérardin; Adrian Fianu; Denis Malvy; Corinne Mussard; Karim Boussaïd; Olivier Rollot; Alain Michault; Bernard-Alex Gaüzere; Gérard Bréart; François Favier
Journal:  BMC Med       Date:  2011-01-14       Impact factor: 8.775

10.  Predictors of Chikungunya rheumatism: a prognostic survey ancillary to the TELECHIK cohort study.

Authors:  Patrick Gérardin; Adrian Fianu; Alain Michault; Corinne Mussard; Karim Boussaïd; Olivier Rollot; Philippe Grivard; Somar Kassab; Eric Bouquillard; Gianandrea Borgherini; Bernard-Alex Gaüzère; Denis Malvy; Gérard Bréart; François Favier
Journal:  Arthritis Res Ther       Date:  2013-01-09       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.